ArticleScientific reports2024

Discovery of a novel piperazine derivative, cmp2: a selective TRPC6 activator suitable for treatment of synaptic deficiency in Alzheimer's disease hippocampal neurons.

Nikita Zernov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.